Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Must be Japanese and live in Japan~* Must be age 20 to 75 years~* Diagnosed less than or equal to 10 years from time of first visit~Exclusion Criteria:~* Anyone who has received etanercept or TNF-inhibitors such as infliximab or adalimumab in the past~* Patient with other rheumatic diseases or conditions that could predispose the patient to infection~* Pregnant or lactating women

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).